Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. PINK /
  3. NYMXF.PINK

Nymox Pharmaceutical Corporation (NYMXF PINK) stock market data APIs

$0.55 0.54(5400%) as of July 25, 2024
Price chart is built with Anychart

Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which is in various clinical trials for the treatment of benign prostatic hyperplasia and low grade localized prostate cancer, as well as is in preclinical studies for hepatocellular carcinoma. The company also develops and markets NicAlert for detecting tobacco product usage; and TobacAlert for detecting second-hand smoke exposure. In addition, it develops drugs for the treatment of Alzheimer's disease. Nymox Pharmaceutical Corporation was founded in 1989 and is headquartered in Nassau, the Bahamas.

Nymox Pharmaceutical Corporation Financial Data Overview

0.01
0.55
-
0.55
0.01
0.01-1.27
31 710 K
93 265 K
-5 000
0
0.229
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'NYMXF',
Type: 'Common Stock',
Name: 'Nymox Pharmaceutical Corporation',
Exchange: 'PINK',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG000FYGR29',
ISIN: NULL,
CUSIP: NULL,
CIK: '1018735',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

Nymox Pharmaceutical Corporation Fundamental Data is available in our Financial Data APIs

  • Net Revenue -5 000
  • EBITDA -1 982 000
  • Earnings Per Share -0.05
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Nymox Pharmaceutical Corporation Earnings via APIs

  • Latest Release 2024-03-29
  • EPS/Forecast 0

Get Nymox Pharmaceutical Corporation End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Nymox Pharmaceutical Corporation latest news via APIs

$250 Million Lawsuit Filed Against AscellaHealth by Nymox Accepted and Summons Issued in California Court

IRVINE, Calif., Nov. 21, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (“Nymox”) (OTC Markets NYMXF) announced today that the California Superior Court, Orange County (OCSC) has a...
  • LAW & LEGAL ISSUES
  • NYMOX PHARMACEUTICAL CORPORATION
  • OTC MARKETS:NYMXF

Nymox Pharmaceutical Corporation Sues AscellaHealth For $250 Million

IRVINE, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- This week, Nymox Pharmaceutical Corporation (“Nymox”) (OTC Markets - NYMXF) was forced to file a lawsuit in California Superior Court, Orange Co...
  • LAW & LEGAL ISSUES
  • NYMOX PHARMACEUTICAL CORPORATION
  • OTC MARKETS:NYMXF
Do you have any questions?
support@eodhistoricaldata.com